Pieris Pharmaceuticals Income After Taxes 1970-1969 | PVLA
Pieris Pharmaceuticals income after taxes from 1970 to 1969. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Pieris Pharmaceuticals Annual Income After Taxes
(Millions of US $) |
Pieris Pharmaceuticals Quarterly Income After Taxes
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
|
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|
